Echo Lake Capital made an offer to acquire Quince Therapeutics, Inc. (NasdaqGS:QNCX) for $58.8 million on March 21, 2023. Echo Lake acquire all the outstanding Common Stock of Quince Therapeutics for a price of $1.6 per share in cash. Echo Lake proposal is not contingent on outside financing and Echo Lake believe can complete customary diligence and negotiate definitive documentation within 30 days.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.11 USD | +4.72% | +11.39% | +5.71% |
Apr. 01 | Quince Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 26 | Transcript : Quince Therapeutics, Inc. - Special Call |
1st Jan change | Capi. | |
---|---|---|
+5.71% | 47.97M | |
+3.13% | 43.43B | |
+48.83% | 41.69B | |
+8.49% | 41.31B | |
-10.82% | 27.14B | |
+8.26% | 25.28B | |
-23.69% | 18.47B | |
+1.58% | 12.33B | |
+32.83% | 12.59B | |
+6.63% | 11.03B |
- Stock Market
- Equities
- QNCX Stock
- News Quince Therapeutics, Inc.
- Echo Lake Capital made an offer to acquire Quince Therapeutics, Inc. for $58.8 million.